Contraception Flashcards
FSH promotes _______ by causing ______ that line each ______ to ________ and _______
ovarian follicular growth; granulosa cells; follicle; proliferate; produce estradiol
LH promotes _______ production in _____ cells adjacent to _____ cells
androgen; theca; granulosa
menstrual cycle: LH surge causes _______, ______ with increased _______ and slowed _______ synthesis
resumption of meiosis in the dominant oocyte; luteinization of granulosa cells; progesterone; estrogen
most reliable predictor of ovulation is what occurrence?
onset of LH surge
menstrual cycle: during the luteal phase, shift is to ____ dominance which _______ and causes ______ changes to the endometrium
progesterone; suppresses new follicular growth; secretory
menstrual cycle: if pregnancy does not occur the corpus luteum declines ____ days after ovulation with a drop in __________ with resultant shedding of the endometrial lining, _______, and ________
9-11; progesterone, estrogen, and inhibin levels; rise in FSH and LH; development of a new follicle
after ovulation the oocyte retains potential for fertilization for ______. sperm remain viable in the reproductive tract for up to _____.
12-24 hours; 120 hours
combined hormonal methods: mechanism of action
estrogen PLUS progestin; prevent ovulation, thicken cervical mucus
_____ is the dominant hormone in combined hormonal contraceptive formulations.
progestin
what is the mechanism of action of progestin in combined hormonal contraceptive formulations? what about estrogen?
progestin diminishes frequency of hypothalamic GnRH pulse frequency, inhibits estrogen-induced LH surge at mic-cycle
estrogen suppresses FSH preventing selection and emergence of dominant follicle
combined contraceptive vaginal ring: mode of action, what does it contain
suppression of ovulation; ethylene vinyl acetate
combined transdermal patch: drawback compared to oral contraceptive pill
higher rate of venous thromboembolism
combined hormonal contraceptive effects on coagulation cascade
- increase levels of procoagulant factors 2, 7, 8, 10 and fibrinogen
- decrease anticoagulant protein S, antithrombin, and tissue factor pathway inhibitor
- induce resistance to natural anticoagulant activated protein C
contraindications to combined hormonal contraceptives
- smokers > 35 years old (increased risk of cardiovascular events)
- history of thromboembolism and stroke
- history of estrogen-dependent tumor
- postpartum: 3-6 weeks after delivery (hypercoagulable state)
progestin only pills: mechanism of action
prevents fertilization from thickening of cervical mucus and slowing ovum transport through decreased tubal motility